V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280008152 | 280008830 | null | 72.6 | Palliative (P) | 2018-09-03 | 2018-10-02 | DOXORUBICIN | N | null | 280026477 | DOXORUBICIN |
| 280008153 | 280005379 | 1.58 | 51 | Palliative (P) | null | 2017-06-12 | Cisplatin | 02 | N | 280026480 | CISPLATIN |
| 280008154 | 280005380 | null | 49.6 | Neo-adjuvant (N) | 2014-09-13 | 2015-03-07 | STS Rhabdo RMS 2005 Vin Cyclo | N | N | 280026482 | RMS 2005 TRIAL |
| 280008155 | 280010494 | 0 | 112 | Curative (C) | 2016-06-07 | 2017-02-07 | STS Rhabdo RMS 2005 2nd Topo Cyclo | 02 | N | 280026485 | RMS 2005 TRIAL |
| 280008156 | 280005382 | 1.49 | 54.35 | Neo-adjuvant (N) | 2016-05-06 | 2016-11-28 | Paclitaxel 80mg/m2 day 1 8 15 | null | null | 280026486 | PACLITAXEL |
| 280008157 | 280005383 | 0 | 64 | Curative (C) | 2018-01-01 | 2018-01-10 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | N | 280026486 | RMS 2005 TRIAL |
| 280008158 | 280005383 | 1.57 | null | Neo-adjuvant (N) | 2015-11-03 | 2015-12-05 | DOXORUBICIN | 2 | N | 280026486 | DOXORUBICIN |
| 280008159 | 280005383 | null | 57.4 | Curative (C) | 2016-02-13 | 2016-04-09 | Cisplatin 7 day | Y | N | 280026486 | CISPLATIN |
| 280008160 | 280011907 | 1.89 | 18.9 | Palliative (P) | 2015-07-21 | 2015-07-26 | Ifosfamide | 02 | N | 280026510 | IFOSFAMIDE |
| 280008161 | 280005384 | 1.73 | 75.7 | Adjuvant (A) | 2017-08-17 | 2017-08-23 | DOXORUBICIN | null | null | 280026513 | DOXORUBICIN |
| 280008162 | 280005384 | null | 68 | null | 2017-03-16 | 2017-06-04 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | Y | 280026513 | IVA |
| 280008163 | 280008834 | 0 | 96 | Curative (C) | null | 2017-01-05 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026519 | IVA |
| 280008164 | 280008835 | 1.7 | null | Curative (C) | null | 2017-12-09 | Cetuximab + Radiotherapy Maint | 01 | Y | 280026523 | CETUXIMAB + RT |
| 280008165 | 280008835 | 1.83 | 65.8 | Curative (C) | 2017-02-17 | 2017-04-08 | CARBOPLATIN + RT | N | N | 280026523 | CARBOPLATIN + RT |
| 280008166 | 280008835 | 1.7 | 66.1 | c | 2016-12-06 | 2017-01-06 | Cisplatin | N | Y | 280026523 | CISPLATIN |
| 280008167 | 280011704 | 1.75 | null | Curative (C) | 2013-06-26 | 2013-07-17 | Cisplatin | 02 | Y | 280026529 | CISPLATIN |
| 280008168 | 280005387 | null | 114 | Adjuvant (A) | 2015-08-26 | 2015-12-20 | DOXORUBICIN | N | N | 280026530 | DOXORUBICIN |
| 280008169 | 280005388 | 1.58 | 17 | Neo-adjuvant (N) | null | 2017-01-09 | Paclitaxel 7 day | N | N | 280026547 | PACLITAXEL |
| 280008170 | 280005389 | 1.8 | 80 | Curative (C) | 2017-04-26 | 2017-05-26 | Cisplatin | Y | N | 280026547 | CISPLATIN |
| 280008171 | 280005390 | null | 15.4 | Curative (C) | 2016-07-17 | 2016-12-11 | STS Rhabdomyosarcoma RMS 2005 IVA | 2 | N | 280026555 | IVA |
| 280008172 | 280008839 | 1.74 | 19.2 | Adjuvant (A) | 2014-06-04 | 2014-06-04 | CARBOPLATIN + RT | 02 | null | 280026556 | CARBOPLATIN + RT |
| 280008173 | 280008839 | 0 | null | Curative (C) | 2017-11-08 | 2017-12-21 | STS Rhabdomyosarcoma RMS 2005 IVA | Y | N | 280026556 | IVA |
| 280008174 | 280011307 | 1.76 | 69.5 | Curative (C) | 2013-06-24 | 2013-07-01 | CARBOPLATIN + RT | 02 | Y | 280026571 | CARBOPLATIN + RT |
| 280008175 | 280011307 | 1.85 | 68.05 | Neo-adjuvant (N) | 2016-11-03 | 2017-02-01 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026571 | IVA |
| 280008176 | 280011307 | 1.49 | 57.4 | Palliative (P) | 2016-05-25 | 2017-08-14 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280026571 | PACLITAXEL |
| 280008177 | 280011307 | 0 | 75.5 | Curative (C) | 2015-12-15 | 2015-12-15 | STS Rhabdo RMS 2005 Vin Cyclo | 01 | N | 280026571 | RMS 2005 TRIAL |
| 280008178 | 280011307 | null | 70.5 | Curative (C) | 2017-04-16 | 2017-05-30 | STS Rhabdomyosarcoma RMS 2005 IVA | N | Y | 280026571 | IVA |
| 280008179 | 280011307 | 1.68 | 64.2 | Curative (C) | 2015-05-28 | 2015-05-28 | Cisplatin | null | null | 280026571 | CISPLATIN |
| 280008180 | 280011307 | 1.73 | null | Adjuvant (A) | 2016-09-14 | 2016-11-12 | CARBOPLATIN + RT | N | Y | 280026571 | CARBOPLATIN + RT |
| 280008181 | 280011307 | 1.7 | 80.2 | Curative (C) | 2016-12-15 | 2017-01-16 | Cetuximab + Radiotherapy Load | N | Y | 280026571 | CETUXIMAB + RT |
| 280008182 | 280012156 | null | 131 | Curative (C) | 2016-03-01 | 2016-05-04 | Cisplatin | N | Y | 280026592 | CISPLATIN |
| 280008183 | 280012156 | 1.59 | 44.2 | Curative (C) | 2016-09-09 | 2016-09-27 | CARBOPLATIN + RT | N | Y | 280026592 | CARBOPLATIN + RT |
| 280008184 | 280005391 | 1.63 | 61 | Neo-adjuvant (N) | null | 2013-08-27 | Cetuximab + Radiotherapy Maint | 2 | N | 280026594 | CETUXIMAB + RT |
| 280008185 | 280008840 | 1.6 | 59 | Curative (C) | 2013-07-10 | 2013-08-02 | Cetuximab + Radiotherapy Maint | N | N | 280026600 | CETUXIMAB + RT |
| 280008186 | 280005392 | 0 | null | Neo-adjuvant (N) | null | 2018-02-15 | STS Rhabdomyosarcoma RMS 2005 VA | 02 | N | 280026606 | RMS 2005 TRIAL |
| 280008187 | 280005392 | null | null | Neo-adjuvant (N) | null | 2014-05-07 | DOXORUBICIN | 02 | null | 280026606 | DOXORUBICIN |
| 280008188 | 280011308 | 1.67 | 66.9 | Neo-adjuvant (N) | 2016-05-18 | 2016-05-18 | Ifosfamide | 02 | null | 280026607 | IFOSFAMIDE |
| 280008189 | 280005394 | 1.6 | 71.4 | Neo-adjuvant (N) | 2016-06-18 | 2016-07-07 | Cetuximab + Radiotherapy Maint | N | Y | 280026610 | CETUXIMAB + RT |
| 280008190 | 280008842 | 1.52 | null | Adjuvant (A) | 2016-02-28 | 2016-02-28 | CARBOPLATIN + RT | 02 | null | 280026614 | CARBOPLATIN + RT |
| 280008191 | 280005395 | 1.78 | 68.1 | null | 2017-09-07 | 2017-10-12 | Cisplatin 7 day | 2 | null | 280026622 | CISPLATIN |
| 280008192 | 280005396 | 1.54 | 52.2 | Neo-adjuvant (N) | 2015-09-14 | 2015-10-12 | Paclitaxel 7 day | N | N | 280026624 | PACLITAXEL |
| 280008193 | 280005398 | 1.94 | null | Neo-adjuvant (N) | 2016-12-13 | 2016-12-30 | DOXORUBICIN | null | null | 280026632 | DOXORUBICIN |
| 280008194 | 280008843 | 1.63 | 91.7 | Neo-adjuvant (N) | 2017-06-13 | 2017-10-22 | CETUXIMAB + RT | null | Y | 280026635 | CETUXIMAB + RT |
| 280008195 | 280005399 | 1.85 | null | Curative (C) | null | 2017-01-10 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280026645 | IVA |
| 280008196 | 280008844 | null | 57.7 | Adjuvant (A) | 2016-10-24 | 2017-03-04 | CARBOPLATIN + RT | 02 | Y | 280026651 | CARBOPLATIN + RT |
| 280008197 | 280005400 | 1.64 | 17.7 | Palliative (P) | 2016-02-04 | 2016-07-18 | PACLITAXEL | null | null | 280026657 | PACLITAXEL |
| 280008198 | 280008845 | null | 57.4 | Palliative (P) | 2015-12-03 | 2016-03-01 | Cisplatin | N | Y | 280026659 | CISPLATIN |
| 280008199 | 280008845 | 0 | 93 | Neo-adjuvant (N) | 2017-11-17 | 2017-11-28 | STS Rhabdomyosarcoma RMS 2005 IVADo | 02 | N | 280026659 | RMS 2005 TRIAL |
| 280008200 | 280008846 | 1.54 | 74.3 | Disease modification (D) | 2014-08-23 | 2014-09-16 | IVA | 02 | N | 280026670 | IVA |
| 280008201 | 280005402 | 0 | 72.6 | Neo-adjuvant (N) | 2017-02-07 | 2017-02-07 | STS Rhabdomyosarcoma RMS 2005 IVADo | N | N | 280026673 | RMS 2005 TRIAL |